Osteoarthritis Trial, Recruiting NCT06681142 Sponsor: University of Alberta Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT06681142
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been regularly experiencing pain, aching, or stiffness in or around the knee for at least 1 month
  • People who complete the screening questionnaire called the PhIT-OA questionnaire

Who may not be able to join:

  • People who have already had a total knee replacement, or who are currently on a waiting list for one
  • People who have had knee surgery within the past 4 months
  • People who have had an acute (sudden) knee injury within the past 6 months
  • People who are not able to speak and read English
  • People who are unable or unwilling to attend a community physiotherapy clinic at the specific dates and times offered by the partnering clinic
  • People who have been diagnosed by a doctor with an inflammatory arthritis condition, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, lupus, or gout
  • People who have been diagnosed by a doctor with fibromyalgia
  • People who have experienced a sudden, severely painful, hot, and swollen joint at any point in the past
  • People who have taken certain medications, including disease-modifying arthritis drugs (csDMARD, bDMARD, or tsDMARD), immunosuppressants, allopurinol, febuxostat, or colchicine (confirm with trial site)
  • People who have had an injection into the knee joint in the past 3 months, or who have one scheduled in the next 3 months
  • People who have previously completed the GLA:D Hip and Knee program at any time

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ross Tsuyuki, University of Alberta

Phone: 780-492-2020

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
13 August 2025
Est. completion
1 September 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Disease specific self-report measure for OA

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov